Vitrolife AB (publ)

SSE:VITR.ST

187.4 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 3,5123,2341,680.8041,245.5721,480.1321,151.3481,046.217856.106722.37510.512452.738362.02356.115297.565274.626225.141188.939171.264120.12103.85596.256103.283
Cost of Revenue 1,7741,454634.714477.905541.48390.224364.508294.805237.55161.394152.183123.72117.84291.4181.74168.89159.27454.74437.19329.48134.61753.921
Gross Profit 1,7381,7801,046.09767.667938.652761.124681.709561.301484.82349.118300.555238.3238.273206.155192.885156.25129.665116.5282.92774.37461.63949.362
Gross Profit Ratio 0.4950.550.6220.6160.6340.6610.6520.6560.6710.6840.6640.6580.6690.6930.7020.6940.6860.680.690.7160.640.478
Reseach & Development Expenses 122143114.4591.75999.51588.45769.11661.5955.73741.92558.87441.20447.17643.14438.57430.66926.88924.18315.81912.22813.96430.642
General & Administrative Expenses 433400259.456114.424119.38299.2799.33494.14680.46759.9655.89145.1750.57682.22438.83135.44928.77524.33920.52520.5925.1133.658
Selling & Marketing Expenses 684602244.285196.927231.582184.537170.279155.686139.86112.098108.11102.02898.3687.55280.27564.86953.10547.24138.85528.21624.30728.306
SG&A 8831,002503.741311.351350.964283.807269.613249.832220.327172.058164.001147.198148.936169.776119.106100.31881.8871.5859.3848.80649.41761.964
Other Expenses -5121.488-11.25-0.013-0.212-0.3561.6660.3570.9232.4620.9290.997-39.8254.797-1.862-0.1380.73-4.3260.298-43.617-165.659
Operating Expenses 1,0051,145619.679391.86450.466372.052338.373313.088276.299213.275221.737188.18197.109173.095162.477129.125108.63196.49370.87361.33219.764-73.053
Operating Income 733654435.379370.015487.946393.915340.856248.841226.135143.34680.39849.72540.91733.0630.40827.12521.03420.02712.05413.04241.875122.415
Operating Income Ratio 0.2090.2020.2590.2970.330.3420.3260.2910.3130.2810.1780.1370.1150.1110.1110.120.1110.1170.10.1260.4351.185
Total Other Income Expenses Net -4,445-11724.59-3.8244.7489.511-2.4210.71718.31911.0810.97-0.3823.9388.1930.1790.089-2.628-4.9883.204-1.318-2.369-5.589
Income Before Tax -3,712537459.969366.191492.694398.583340.915248.93226.84146.92479.78849.73845.10241.25330.58727.21418.40615.03915.25811.72439.506116.826
Income Before Tax Ratio -1.0570.1660.2740.2940.3330.3460.3260.2910.3140.2880.1760.1370.1270.1390.1110.1210.0970.0880.1270.1130.411.131
Income Tax Expense 139143116.40578.325108.85587.88676.31357.71843.47937.45623.08823.19114.45812.071-3.782-2.986-17.651-0.16-0.399-0.212-5.178-0.636
Net Income -3,851394341286.845382.785309.697263.64190.368182.845109.10956.274333.77230.3629.18234.11429.99536.05715.19914.85911.93644.684116.503
Net Income Ratio -1.0970.1220.2030.230.2590.2690.2520.2220.2530.2140.1240.9220.0850.0980.1240.1330.1910.0890.1240.1150.4641.128
EPS -28.442.912.972.643.532.852.431.751.681.090.573.410.310.30.350.30.360.150.160.140.491.27
EPS Diluted -28.442.912.972.643.532.852.431.751.681.090.573.410.310.30.350.30.360.150.160.140.491.27
EBITDA 1,158995577.042443.852594.978482.589407.581304.198262.902168.418123.76177.40141.41150.83430.40827.12520.67816.59422.16513.04244.271124.694
EBITDA Ratio 0.330.3080.3430.3560.4020.4190.390.3550.3640.330.2730.2140.1160.1710.1110.120.1090.0970.1850.1260.461.207